Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve audited financial result ....
Awaiting price reaction for this filing.
Citurgia Biochemicals has informed BSE that its Board of Directors will meet on Friday, 30 May 2025 to consider and approve the audited financial results (standalone) for the quarter and financial year ended 31 March 2025. The filing is a routine compliance disclosure under SEBI LODR Regulation 29. The trading window for the company's shares has been closed since 1 April 2025 and will reopen 48 hours after the results are announced. No financial figures, projections, or material business items are disclosed in this intimation.
This is a standard pre-results announcement and does not carry any new fundamental information. Shareholders should await the actual audited results on 30 May 2025 for any meaningful insight into the company's FY25 performance. The stock may see some activity once the results are published and the trading window reopens.